Table 3.
Associations of PR and NF2 expression with meningioma.
| Model 1 | Model 2 | ||||
|---|---|---|---|---|---|
| Variables | N | OR (95% CI) | P-value | Mean (95% CI) | P-value |
| EXPRESSION OF PR | |||||
| 1st Quartile (≤2.63) | 28 | 11.7 (4.17–32.9) | <0.001 | 12.8 (4.14–39.3) | <0.001 |
| 2nd−4th Quartile (≥5.27) | 84 | Reference | Reference | ||
| EXPRESSION OF NF2 | |||||
| 1st−2nd Quartile (≤5.26) | 56 | 4.23 (1.85–9.67) | 0.001 | 4.94 (2.03–11.9) | <0.001 |
| 3rd−4th Quartile (≥5.27) | 56 | Reference | Reference | ||
PR, progesterone receptors; NF2, neurofibromatosis-2.
Model 1 unadjusted.
Model 2 adjusted for age of menarche, number of children, length of menstrual cycle, duration of exogenous progesterone, family history of breast cancer.
The bold values are the values that statistically significant.